Cancer stem cells linked to drug resistance

Researchers at the University of California, San Diego School of Medicine have discovered a molecule, or biomarker, called CD61 on the surface of drug-resistant tumors that appears responsible for inducing tumor metastasis by enhancing the stem cell-like properties of cancer cells. The findings may point to new therapeutic opportunities for reversing drug resistance in a range of cancers, including those in the lung, pancreas and breast. Read more here.